What Is Mirzacan 30 mg?
Mirzacan 30 mg (Mirtazapine) is a prescription antidepressant medicine containing 30 mg of mirtazapine, an active ingredient used primarily for the treatment of major depressive disorder (MDD) in adults.
Major depressive disorder is a mental health condition that can affect mood, interest in daily activities, sleep, appetite, energy, concentration and overall quality of life.
Mirtazapine belongs to a group of medicines commonly classified as tetracyclic antidepressants. It is also described as a noradrenergic and specific serotonergic antidepressant (NaSSA).
Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine primarily acts by modifying neurotransmitter signaling through specific receptors.
It enhances noradrenergic and serotonergic neurotransmission through central alpha-2 adrenergic receptor antagonism and blocks certain serotonin and histamine receptors.
These actions contribute to its antidepressant effects and characteristic adverse-effect profile, including sleepiness and increased appetite.
Mirzacan 30 mg may be prescribed when a healthcare professional determines that mirtazapine is an appropriate treatment for depression.
Important: Mirtazapine is not an immediate-acting antidepressant. Meaningful improvement in depressive symptoms may take several weeks, and treatment requires regular medical follow-up.
How Does Mirzacan 30 mg Work?
1. Modulates Noradrenergic Neurotransmission
Mirtazapine blocks central presynaptic alpha-2 adrenergic receptors.
This increases noradrenergic neurotransmission in the central nervous system.
2. Enhances Serotonergic Signaling
Through alpha-2 receptor antagonism, mirtazapine also enhances certain serotonergic pathways.
3. Blocks Specific Serotonin Receptors
Mirtazapine antagonizes serotonin 5-HT2 and 5-HT3 receptors.
This contributes to its distinctive pharmacological profile compared with SSRIs.
4. Blocks Histamine H1 Receptors
Mirtazapine has potent histamine H1 receptor antagonist activity.
This contributes to its sedating effects and may also contribute to increased appetite.
5. Supports Antidepressant Treatment
By modifying neurotransmitter signaling, mirtazapine can help improve depressive symptoms over time.
6. Influences Sleep
Its sedating properties may improve sleep in some patients experiencing depression-related insomnia.
However, it is not primarily approved as a sleeping medicine.
7. Influences Appetite
Mirtazapine may increase appetite and body weight.
These effects require monitoring, particularly in patients with metabolic risk factors.
Uses of Mirzacan 30 mg
1. Major Depressive Disorder
The principal established indication for mirtazapine is the treatment of major depressive disorder in adults.
Symptoms may include:
- Persistent low mood
- Loss of interest in activities
- Reduced motivation
- Changes in sleep
- Changes in appetite
- Fatigue
- Difficulty concentrating
- Feelings of worthlessness
- Reduced enjoyment of everyday life
2. Depression With Sleep Disturbances
Mirtazapine may be considered for patients with depression who also experience significant sleep difficulties.
Its sedating effects can be relevant when selecting an antidepressant.
3. Depression With Reduced Appetite
Some patients with depression experience poor appetite and unintentional weight loss.
Because mirtazapine may increase appetite, this effect may influence a clinician’s treatment selection.
However, it should not be used solely as an appetite stimulant without appropriate medical assessment.
4. Depression With Anxiety Symptoms
Patients with major depressive disorder may also experience anxiety symptoms.
Mirtazapine may help improve anxiety symptoms associated with depression as the underlying condition responds to treatment.
5. Generalized Anxiety Disorder – Off-Label
Mirtazapine has been studied and prescribed off-label for certain anxiety disorders.
However, it is not FDA-approved specifically for generalized anxiety disorder.
6. Insomnia – Off-Label
Mirtazapine is sometimes prescribed off-label for sleep disturbances.
Its use solely for insomnia requires careful consideration because of adverse effects such as daytime sedation and weight gain.
7. Other Specialist-Directed Applications
Healthcare professionals may occasionally prescribe mirtazapine for other conditions based on individual clinical circumstances.
Such uses should not be confused with its established approval for major depressive disorder.
Important: Mirzacan 30 mg should be used only for a diagnosed condition under medical supervision.
How to Take Mirzacan 30 mg
Mirzacan 30 mg should be taken exactly as prescribed by a qualified healthcare professional.
General Administration Instructions
- Confirm the prescribed dose and tablet strength.
- Take the medicine according to the prescribed schedule.
- Swallow the tablet with water if it is a conventional oral tablet.
- Follow the product instructions if supplied as a different formulation.
- Take it consistently at the recommended time.
- Do not increase or reduce the dose independently.
- Avoid stopping treatment suddenly without medical advice.
- Inform the prescriber about all other medicines.
- Report significant mood or behavioral changes.
- Attend regular follow-up appointments.
Dosage Information
For adults with major depressive disorder, standard mirtazapine prescribing information generally recommends:
| Dosage Detail | General Reference |
|---|---|
| Typical Initial Dose | 15 mg once daily |
| Usual Administration | Once daily, preferably in the evening |
| Available Treatment Doses | Commonly 15–45 mg daily |
| Maximum Recommended Adult Dose | 45 mg daily |
| Dose Adjustments | Based on clinical response and tolerability |
Mirzacan 30 mg contains 30 mg of mirtazapine. It is not necessarily the appropriate starting dose for every patient.
Dosage adjustments are generally made only after sufficient time to evaluate response, commonly at intervals of at least one to two weeks.
When Should Mirzacan 30 mg Be Taken?
Mirtazapine is commonly taken once daily in the evening, preferably before bedtime, because it can cause sleepiness.
Follow the prescriber’s specific instructions.
Can Mirzacan 30 mg Be Taken With Food?
Mirtazapine may generally be taken with or without food.
What If a Dose Is Missed?
If a dose is missed, follow the prescriber’s instructions or product leaflet.
Do not take two doses together to make up for a missed dose.
Can Mirzacan 30 mg Be Stopped Suddenly?
Abrupt discontinuation may cause symptoms such as:
- Dizziness
- Nausea
- Headache
- Irritability
- Anxiety
- Sleep disturbances
- Unusual dreams
- Sensory disturbances
A healthcare professional may recommend gradual dose reduction when discontinuing treatment.
How Long Does Mirzacan 30 mg Take to Work?
Mirtazapine begins affecting neurotransmitter receptors after administration, but its antidepressant benefits generally develop over time.
First Few Days
Sleepiness or changes in appetite may occur before a noticeable improvement in mood.
First 1–2 Weeks
Some patients may begin to experience improvements in sleep, appetite or certain depressive symptoms.
Approximately 2–4 Weeks
More noticeable improvement in mood and other depressive symptoms may occur.
Approximately 4–6 Weeks or Longer
A fuller antidepressant response may require several weeks of consistent treatment.
Important: Individual response varies. If symptoms worsen or suicidal thoughts occur, seek immediate medical assessment rather than waiting for the medicine to take effect.
Common Side Effects
Possible side effects of mirtazapine include:
- Sleepiness
- Drowsiness
- Increased appetite
- Weight gain
- Dry mouth
- Constipation
- Dizziness
- Fatigue
- Increased cholesterol
- Abnormal dreams
Some side effects may become less noticeable over time, while others may persist.
Serious Side Effects
Seek urgent medical attention if any of the following occur:
- Suicidal thoughts or behavior
- Severe allergic reactions
- Difficulty breathing
- Severe skin reactions
- High fever with agitation or muscle rigidity
- Seizures
- Severe confusion
- Fainting or serious heart rhythm symptoms
- Unusual bleeding
- Signs of severe infection
- Severe mood elevation or manic symptoms
Important Serious Adverse Reactions
Suicidal Thoughts and Behaviors: Antidepressants carry an FDA boxed warning regarding increased risk of suicidal thoughts and behaviors in pediatric and young adult patients.
Serotonin Syndrome: A potentially life-threatening reaction may occur, particularly when mirtazapine is combined with other serotonergic medicines.
Agranulocytosis and Neutropenia: Rare but serious reductions in certain white blood cells have been reported.
Severe Skin Reactions: Serious reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported.
QT Prolongation: Mirtazapine may be associated with QT prolongation and serious heart rhythm disturbances, particularly in susceptible patients.
Mania or Hypomania: Antidepressant treatment may trigger manic or hypomanic episodes in patients with bipolar disorder.
Hyponatremia: Low blood sodium levels may occur, sometimes associated with the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Contraindications & Precautions
1. Allergy to Mirtazapine
Patients with known hypersensitivity to mirtazapine or formulation ingredients should not take the medicine.
2. Monoamine Oxidase Inhibitors (MAOIs)
Mirtazapine must not be combined with MAOIs used to treat psychiatric disorders.
Appropriate separation periods are required when switching between these medicines.
3. Suicidal Thoughts
Patients, families and caregivers should monitor for worsening depression, suicidal thoughts or unusual behavioral changes, particularly during treatment initiation and dose changes.
4. Bipolar Disorder
Patients should be screened for a personal or family history of bipolar disorder before starting antidepressant treatment.
5. Liver Disease
Patients with liver impairment may have reduced clearance of mirtazapine and require dose assessment.
6. Kidney Disease
Patients with moderate to severe kidney impairment may require additional caution.
7. Heart Conditions
Patients with a history of arrhythmias, QT prolongation or other significant cardiovascular conditions should inform their prescriber.
8. Weight Gain
Mirtazapine may increase appetite and body weight.
Weight monitoring may be appropriate during treatment.
9. Cholesterol and Triglycerides
Mirtazapine may increase blood lipid levels.
Monitoring may be appropriate for patients with metabolic risk factors.
10. Glaucoma
Mirtazapine may cause pupil dilation and can trigger angle-closure glaucoma in susceptible individuals.
11. Seizure Disorders
Patients with a history of seizures require medical assessment.
12. Low Blood Sodium
Older adults and patients taking certain diuretics may be at increased risk of hyponatremia.
13. Pregnancy
Use during pregnancy requires individualized assessment of maternal benefits and potential fetal risks.
14. Breastfeeding
Mirtazapine passes into breast milk in small amounts.
Treatment decisions should be made with a healthcare professional.
15. Older Adults
Older adults may be more sensitive to sedation, dizziness and certain adverse effects.
16. Alcohol and Sedatives
Alcohol and other sedating substances may increase drowsiness and impair coordination.
17. Medication Interactions
Potentially important interactions include:
- MAO inhibitors
- SSRIs
- SNRIs
- Tramadol
- Linezolid
- Certain migraine medicines
- Lithium
- St. John’s wort
- Benzodiazepines
- Alcohol
- Other sedating medicines
- Medicines associated with QT prolongation
- Strong CYP enzyme inhibitors or inducers
A healthcare professional should review the complete medication list.
18. Medical Monitoring
Healthcare professionals may monitor:
- Depressive symptoms
- Suicidal thoughts and behavioral changes
- Sleep patterns
- Appetite
- Body weight
- Blood lipid levels when indicated
- Signs of serotonin syndrome
- Symptoms of mania or hypomania
- Blood sodium when indicated
- Medication interactions
- Treatment response
- Discontinuation symptoms
Advantages
- Established antidepressant treatment.
- Approved for major depressive disorder in adults.
- Once-daily oral administration.
- May improve depression-related sleep disturbances.
- May be considered when depression is accompanied by reduced appetite.
- Distinct pharmacological mechanism compared with SSRIs.
- Available in several strengths.
- Can be used in individualized antidepressant treatment plans.
- May help improve mood and daily functioning.
- Has established clinical evidence for major depressive disorder.
Disadvantages / Limitations
- May cause significant drowsiness.
- May increase appetite.
- May cause weight gain.
- May increase cholesterol or triglycerides.
- May cause dry mouth.
- May cause constipation.
- May cause dizziness.
- May impair driving or machinery operation.
- May interact with other antidepressants.
- May contribute to serotonin syndrome.
- May trigger mania in susceptible patients.
- May cause discontinuation symptoms if stopped abruptly.
- Requires monitoring for suicidal thoughts.
- May cause rare serious blood disorders.
- May cause hyponatremia.
- May cause serious skin reactions.
- Requires caution in liver and kidney impairment.
- Antidepressant benefits may take several weeks.
Important Notes
Brand Name: Mirzacan.
Generic Name: Mirtazapine.
Strength: 30 mg.
Dosage Form: Oral Tablet, subject to packaging verification.
Drug Class: Tetracyclic Antidepressant.
Therapeutic Category: Antidepressant Medicines.
Primary Indication: Major Depressive Disorder.
Mechanism of Action: Central alpha-2 adrenergic receptor antagonism, serotonin receptor antagonism and histamine H1 receptor antagonism.
Administration Route: Oral.
Typical Administration: Once daily, generally in the evening.
Maximum Recommended Adult Dose: 45 mg daily under medical supervision.
Common Side Effects: Sleepiness, increased appetite, weight gain, dry mouth and constipation.
Important Warning: Monitor for suicidal thoughts and behavioral changes, especially in younger patients.
Discontinuation: Gradual dose reduction may be necessary.
Prescription Status: Prescription-Only Medicine.
Storage: Follow manufacturer instructions.
Frequently Asked Questions
1. What is Mirzacan 30 mg used for?
Mirzacan 30 mg contains mirtazapine, an antidepressant used primarily for the treatment of major depressive disorder in adults.
2. What is the active ingredient in Mirzacan 30 mg?
The stated active ingredient is mirtazapine 30 mg.
3. Is Mirzacan 30 mg an antidepressant?
Yes. Mirtazapine is classified as a tetracyclic antidepressant.
4. How does Mirzacan 30 mg work?
Mirtazapine modifies noradrenergic and serotonergic neurotransmission through specific receptor interactions.
5. Can Mirzacan 30 mg treat depression?
Mirtazapine is an established treatment for major depressive disorder in adults.
6. Can Mirzacan 30 mg help with sleep?
Mirtazapine can cause sedation and may improve sleep in some patients with depression-related sleep disturbances.
































































